ARF1 regulates the Rho/MLC pathway to control EGF-dependent breast cancer cell invasion
about
Breast Cancer-Derived Extracellular Vesicles: Characterization and Contribution to the Metastatic PhenotypeExtracellular vesicles in cancer: exosomes, microvesicles and the emerging role of large oncosomesExtracellular microvesicles and invadopodia mediate non-overlapping modes of tumor cell invasion.Creutzfeldt-Jakob Disease Subtype-Specific Regional and Temporal Regulation of ADP Ribosylation Factor-1-Dependent Rho/MLC Pathway at Pre-Clinical Stage.A Novel Peptide for Simultaneously Enhanced Treatment of Head and Neck Cancer and Mitigation of Oral Mucositis.The small GTPase ADP-Ribosylation Factor 1 mediates the sensitivity of triple negative breast cancer cells to EGFR tyrosine kinase inhibitors.ADP-ribosylation factor 1 expression regulates epithelial-mesenchymal transition and predicts poor clinical outcome in triple-negative breast cancer.Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease.Resveratrol suppresses breast cancer cell invasion by inactivating a RhoA/YAP signaling axis.MS/MS-based strategies for proteomic profiling of invasive cell structures.Membrane microparticles: shedding new light into cancer cell communication.ADP-ribosylation factor 1 (ARF1) takes part in cell proliferation and cell adhesion-mediated drug resistance (CAM-DR).α-TEA inhibits the growth and motility of human colon cancer cells via targeting RhoA/ROCK signalingEndothelin-1 receptor drives invadopodia: Exploiting how β-arrestin-1 guides the way.MicroRNAs in extracellular vesicles: potential cancer biomarkers.Biology and biogenesis of shed microvesicles.Arf proteins in cancer cell migration.Plasticity of tumor cell invasion: governance by growth factors and cytokines.Role of the Golgi Apparatus in the Blood-Brain Barrier: Golgi Protection May Be a Targeted Therapy for Neurological Diseases.5-Azacytidine promotes invadopodia formation and tumor metastasis through the upregulation of PI3K in ovarian cancer cells.Nck deficiency is associated with delayed breast carcinoma progression and reduced metastasis.Cell survival and protein secretion associated with Golgi integrity in response to Golgi stress-inducing agents.Arf6 and its ZEB1-EPB41L5 mesenchymal axis are required for both mesenchymal- and amoeboid-type invasion of cancer cells.Shedding light on the cell biology of extracellular vesicles.MMP Secretion Rate and Inter-invadopodia Spacing Collectively Govern Cancer Invasiveness.Arf GAPs and molecular motors.Association between epidermal growth factor receptor amplification and ADP-ribosylation factor 1 methylation in human glioblastoma.NEDD9 stimulated MMP9 secretion is required for invadopodia formation in oral squamous cell carcinoma.Tumor-Derived Apoptotic Vesicles: With Death They Do Part.
P2860
Q26776113-857ACA50-ED47-46FB-9558-1C2EE0DC346FQ26825792-1FA84ED6-C665-418A-8692-845845724A70Q30667736-F8737D15-E789-4871-A0E0-DEBF651698C9Q35610507-863F498A-C973-437F-9B56-530FBE09546AQ35980854-BA765F0B-89DF-4ED6-B49C-FBD868EA5DD3Q36839141-5A1F0B76-4158-483A-87F4-243578A218A5Q37085887-2B0AF3CF-6E66-44E7-A286-7DD876717D3AQ37639444-9F747B93-EA21-4BCE-B35E-2A0A9A6F5E42Q37680062-90E96D43-24BD-429E-AA22-A01BF285D22AQ38258895-C48C0AF3-0A85-4520-8DFE-5A2A84277310Q38569109-D6698820-E869-43BE-9958-8E2A588E69B9Q38714809-15263545-DCDC-4136-9DFE-DE162445BA30Q38757132-C216D191-E61E-488C-9B99-BCB5F5D4C982Q38815885-A07F2E40-F1FF-4A60-B0CC-DA8D8A2AFB07Q38887851-A9CCB3F2-0462-4CA2-B398-6506377A2396Q38919574-67D4EEBA-8B0D-4E58-98B8-525587774316Q38944847-6692C2FE-C3A0-4F96-B786-A1536BF6ACB0Q38963431-F7C4E307-0E59-4E5A-8EDB-6D075A33146AQ39449749-EAAC62E0-98BD-4B35-ABD7-3A41090D1543Q41694243-803152EB-BEFA-484A-85DE-706D85B8C99CQ47625162-20E96664-5570-4FA8-94FE-745F275891AAQ48170630-F2F44D6E-F440-4B8E-A203-E5898640C763Q48295154-FEDB334B-9D5F-45FA-8A0E-F2EB01EC6AE1Q50018560-F9EF1EB4-49F5-4D08-A73E-8E312B3CA772Q50134416-28B6B3F6-4A60-4F99-9E65-D20F3CB4E60EQ51042462-F6578A28-C2A0-4B48-B2D7-9ACB51605B66Q52090905-FE5518B9-3786-4B02-9854-759A517F4F2BQ55012871-3C05C535-C4C4-4B94-BF03-25F7B2B12034Q55035002-E98F5DB7-4A01-4CB7-AF48-11E1E895E91F
P2860
ARF1 regulates the Rho/MLC pathway to control EGF-dependent breast cancer cell invasion
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
ARF1 regulates the Rho/MLC pathway to control EGF-dependent breast cancer cell invasion
@ast
ARF1 regulates the Rho/MLC pathway to control EGF-dependent breast cancer cell invasion
@en
type
label
ARF1 regulates the Rho/MLC pathway to control EGF-dependent breast cancer cell invasion
@ast
ARF1 regulates the Rho/MLC pathway to control EGF-dependent breast cancer cell invasion
@en
prefLabel
ARF1 regulates the Rho/MLC pathway to control EGF-dependent breast cancer cell invasion
@ast
ARF1 regulates the Rho/MLC pathway to control EGF-dependent breast cancer cell invasion
@en
P2093
P2860
P356
P1476
ARF1 regulates the Rho/MLC pathway to control EGF-dependent breast cancer cell invasion
@en
P2093
Audrey Claing
Sabrina Schlienger
Shirley Campbell
P2860
P356
10.1091/MBC.E13-06-0335
P577
2013-11-06T00:00:00Z